Someone with a lot of money has taken a bullish stance on Gilead Sciences (NASDAQ:GILD).
Traders should know this.
We have noted that today with pride of place in the history of public choices that we trace here at Benzinga.
Whether it's a foundation or just a wealthy person, we don't know. But when something like this happens to a GILD, it often means that someone knows something is about to happen.
So how do we know what this whale just did?
Today, Benzinga's options scanner found 14 unusual option deals for Gilead Sciences.
This is not normal.
The general trend for senior traders is 50% bullish and 50% bearish.
Of all the privates we found, 6 puts totaled $727,842 and 8 calls totaled $472,590.
What is the target price?
Given the volume and open interest in these contracts, it appears that whales have been targeting Gilead Sciences' $65.0 to $90.0 price range over the past three months.
Trends: Jim Cramer Says It's Time to Buy Amazon Stock, JPMorgan Insider Says, As Analysts Call It
Recommended Read: Stoner Icon Cheech Marin Brings Solid Resin Concentrate to the State Marijuana Market
Developing volume and open interest
An open interest and volume review is an informative way to perform due diligence on a security.
This data can help you track liquidity and interest in Gilead Sciences options for a given exercise price.
Below we can note the evolution of volume and open interest in calls and puts, respectively, of all Gilead Sciences whale positions in the $65.0 to $90.0 strike price range over the past 30 days.
The volume of Gilead Sciences options and open interest over the past 30 days
The main options selected are:
|Code||hole / call||Commercial type||feeling||Example: date||The price has arrived||Total trade price||express interest||amount|
|doctrine||good||commerce||bubble||06/16/23||$80.00||160.5000 USD||2.9 k||912|
Where is Gilead Sciences located now?
With a volume of 6,178,282, the price of GILD fell 3.84% to $76.78. RSI indicators indicate that the underlying asset may be in the oversold zone. The following results will be published after 41 days.
What the experts say about Gilead Sciences:
RBC Capital has decided to maintain Gilead Sciences' sector performance rating, which currently has a price target of $86.
Options are a riskier asset than just stock trading, but they have a higher profit potential. Serious options traders manage this risk by learning daily, entering and exiting trades, following more than one indicator, and closely monitoring the markets.
If you want to stay up to date with the latest Gilead Sciences options trading news, Benzinga Pro will provide you with real time options trading alerts.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Retirement can be a difficult part of life and a financial advisor can help. Finding a qualified financial advisor is not difficult. The free SmartAsset tool connects you with up to three financial advisors serving your area, and you can interview their advisors for free to decide which one is right for you. If you're ready to find a counselor to help you reach your financial goals, get started now.
This article "Extraordinary Options Activity in Gilead Sciences" originally appeared on Benzinga.com.